Predicción y previsión de precio de The Oncology Institute, Inc. (STLN)STLNThe Oncology Institute, Inc.

Alphio's STLN stock price prediction model matches the current The Oncology Institute, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $6.50 (-0.38%). The 1-week path is $6.61 (+1.34%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Starling Oncology, Inc. appears to be a good buy right now, especially considering its recent performance and growth trajectory. The current price is $6.71, which is well below the projected upper band of $7.34 based on Fibonacci levels, indicating potential for upward movement. Additionally, the stock has shown a year-to-date change of +30.80%, reflecting strong momentum. However, the main risk is the negative net income, which was -$9,789,000 in Q2 2026, indicating ongoing financial challenges that investors should monitor closely.

The Oncology Institute, Inc. (STLN) last closed at $6.5250001, losing -1.88%. These facts feed the 1-day and 1-week STLN price prediction above.